Nathalie Y.R. Agar

Brigham and Women's Hospital — United States

Medicine · Health Sciences

50h-index8.9kcitations405works0.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(186), Cancer, Hypoxia, and Metabolism(134), ATP Synthase and ATPases Research(82), Mass Spectrometry Techniques and Applications(54), Metabolomics and Mass Spectrometry Studies(52)

Publications405 total

Spatiotemporal metabolic mapping reveals diet-independent remodeling of the postnatal mouse brain
npj Metabolic Health and Disease·2026Open Access
Characterization of a pathogenic subpopulation of human glioma associated macrophages linked to glioma progression
Cancer Cell·2026Open Access
Spatial Profiling of Elements through Matrix-Assisted Laser Desorption Ionization Mass Spectrometry Imaging
Analytical Chemistry·2025
TMET-32. Cell-intrinsic pyrimidine synthesis pathway choice in human brain and glioma
Neuro-Oncology·2025Open Access
TMET-30. Uncovering the metabolic programs underlying malignant cell state heterogeneity in glioblastoma
Neuro-Oncology·2025· 1 citedOpen Access
INNV-33. Investigative needle core biopsies support multimodal deep-data generation in glioblastoma
Neuro-Oncology·2025
IMMU-67. On-Treatment Spatiotemporal Profiling of Glioblastoma During Oncolytic ImmunoTherapy
Neuro-Oncology·2025Open Access
TMIC-37. A pathogenic subpopulation of human glioma associated macrophages linked to glioma progression
Neuro-Oncology·2025Open Access
TMET-54. Rewiring of cortical glucose metabolism fuels human brain cancer growth
Neuro-Oncology·2025Open Access
EXTH-126. The H3K27M oncoprotein induces replication stress and ATR inhibitor sensitivity
Neuro-Oncology·2025Open Access
CTIM-35. MULTI-OMIC AND SINGLE CELL ASSESSMENT OF SERIAL BIOPSIES REVEALS RESPONSES TO CAN-3110 ONCOLYTIC IMMUNOTHERAPY IN RECURRENT GLIOBLASTOMA THAT ARE NOT EVIDENT BY ROUTINE CLINICAL ANALYSES
Neuro-Oncology·2025Open Access
TMET-20. Lipid-dependent regulation of lineage specification and tumor growth In H3K27M-mutant gliomas
Neuro-Oncology·2025Open Access
CTNI-62. A SURGICAL WINDOW-OF-OPPORTUNITY TRIAL OF NIRAPARIB IN RECURRENT IDH-MUTANT GLIOMAS
Neuro-Oncology·2025Open Access
TMIC-70. Integrative spatiotemporal proteomic and metabolomic characterization of immune infiltration following intracranial injection of oncolytic immunotherapy in glioblastoma patients
Neuro-Oncology·2025Open Access
Serial multiomics uncovers anti-glioblastoma responses not evident by routine clinical analyses
Science Translational Medicine·2025· 7 cited
Window of opportunity evaluation of blood–brain barrier permeability heterogeneity within and across high-grade glioma patients
Neuro-Oncology·2025
Rewiring of cortical glucose metabolism fuels human brain cancer growth
Nature·2025· 16 citedOpen Access
Data from Preclinical Modeling of Navtemadlin Pharmacokinetics, Pharmacodynamics, and Efficacy in IDH–Wild-type Glioblastoma
2025Open Access
Supplementary Data1 from Preclinical Modeling of Navtemadlin Pharmacokinetics, Pharmacodynamics, and Efficacy in IDH–Wild-type Glioblastoma
2025Open Access
Nitrogen metabolism profiling reveals cell state-specific pyrimidine synthesis pathway choice
2025· 1 citedOpen Access
page 1 of 21Next →

Frequent Co-authors

Sandro Santagata(18), Michael S. Regan(14), David Calligaris(13), Keith L. Ligon(12), Isaiah Norton(11), Alexandra J. Golby(10), Sylwia A. Stopka(9), Jeffrey N. Agar(9), Jann N. Sarkaria(8), William F. Elmquist(6), Lívia S. Eberlin(6), R. Graham Cooks(6), Ferenc A. Jólesz(6), Elizabeth C. Randall(6), Ian F. Dunn(5), Walid M. Abdelmoula(5), Shakti Ramkissoon(4), Ian F. Dunn(4), Xiaohui Liu(4), Jennifer L. Ide(4)